CompletedNot Applicable

Retrospective Analysis of the Efficacy of Morphine Gel to Treat Pain Associated With Perineal RadioDermatitis

France17 participantsStarted 2024-12-01

Plain-language summary

Retrospective study evaluating the efficacy of a pharmacy-prepared Morphine gel used in clinics for the treatment of pain associated with perineal radiodermatitis. The main aim of this study is to evaluate the efficacy of Morphine Gel (MG) in pain management.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 years and older; * Use of a local analgesic treatment based on Morphine gel for pain associated with perineal radiodermatitis. * Patients not relieved by prescribed systemic treatments (per-os or intravenous) * Patients treated with radiotherapy for a perineal tumor, whether or not associated with medical treatment such as chemotherapy. * Minimum grade of radiodermatitis: Grade II Exclusion Criteria: * Patients who have not used the prescribed morphine gel * Minor patients * Patients using morphine gel for wounds other than radiodermatitis * Patients who object to the re-use of their data

What they're measuring

Efficacy of morphine gel (GM) in the treatment of pain in perineal radiodermatitis

Timeframe: between baseline and day2 to day21

Trial details

NCT IDNCT07207889

SponsorInstitut Curie

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Dermatitis, Radiation Induced trials